Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis

Abstract Background The impact of smoking on TNF inhibition (TNFi) therapy is unclear. We examined the effect of smoking on all-cause and cause-specific TNFi discontinuation in axial spondyloarthritis (axSpA). Methods We used longitudinal data from the British Society for Rheumatology Biologics Regi...

Full description

Bibliographic Details
Main Authors: Sizheng Steven Zhao, Kazuki Yoshida, Gareth T. Jones, David M. Hughes, Stephen J. Duffield, Sara K. Tedeschi, Houchen Lyu, Robert J. Moots, Daniel H. Solomon, Nicola J. Goodson
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Arthritis Research & Therapy
Subjects:
Axial spondyloarthritis
Ankylosing spondylitis
TNF inhibitor
Biologic DMARDs
Persistence
Effectiveness
Online Access:http://link.springer.com/article/10.1186/s13075-019-1958-z

Internet

http://link.springer.com/article/10.1186/s13075-019-1958-z

Similar Items